IL-10 helps control pathogen load during high-level bacteremia

Journal of Immunology

Volumn 181, Issue 3, 2008, Pages 2076-2083

  Londoño, Diana ^a   Marques, Adriana ^b   Hornung, Ronald L ^c   Cadavid, Diego ^a,d  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c SAIC FREDERICK INC   (United States)

^d BIOGEN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; NEUTRALIZING ANTIBODY; RAG2 PROTEIN; TUMOR NECROSIS FACTOR; ANTIBODY; DNA BINDING PROTEIN; RAG2 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BACTEREMIA; BLOOD; BORRELIA; BORRELIA INFECTION; BORRELIA TURICATAE; CELL PROTECTION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE CONTROL; ENZYME INHIBITION; FEMALE; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; LEUKOCYTE; MORTALITY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PATHOGENESIS; PHAGOCYTOSIS; PRIORITY JOURNAL; RELAPSE; SPIROCHETE INFECTION; SPLEEN; SPLEEN CELL; ANIMAL; BIOSYNTHESIS; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; PATHOGENICITY; PATHOLOGY; SURVIVAL RATE;

ANIMALS; ANTIBODIES; APOPTOSIS; BACTEREMIA; BORRELIA; BORRELIA INFECTIONS; DNA-BINDING PROTEINS; FEMALE; INTERFERON TYPE II; INTERLEUKIN-10; KILLER CELLS, NATURAL; MICE; MICE, KNOCKOUT; SPLEEN; SURVIVAL RATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 49649092660     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.3.2076     Document Type: Article

References (51)

1. Angus, D. C., W. T. Linde-Zwirble, J. Lidicker, G. Clermont, J. Carcillo, and M. R. Pinsky. 2001. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29: 1303-1310.
2. Barbour, A. G., and S. F. Hayes. 1986. Biology of Borrelia species. Microbiol. Rev. 50: 381-400.
3. Newman, K., Jr., and R. C. Johnson. 1984. T-cell-independent elimination of Borrelia turicatae. Infect. Immun. 45: 572-576.
4. Alugupalli, K. R., R. M. Gerstein, J. Chen, E. Szomolanyi-Tsuda, R. T. Woodland, and J. M. Leong. 2003. The resolution of relapsing fever borreliosis requires IgM and is concurrent with expansion of B1b lymphocytes. J. Immunol. 170: 3819-3827.
5. Belperron, A. A., C. M. Dailey, and L. K. Bockenstedt. 2005. Infection-induced marginal zone B cell production of Borrelia hermsii-specific antibody is impaired in the absence of CD1d. J. Immunol. 174: 5681-5686.
6. Gelderblom, H., J. Schmidt, D. Londono, Y. Bai, J. Quandt, R. Hornung, A. Marques, R. Martin, and D. Cadavid. 2007. Role of interleukin 10 during persistent infection with the relapsing fever spirochete Borrelia turicatae. Am. J. Pathol. 170: 251-262.
7. Cadavid, D., E. Garcia, and H. Gelderblom. 2007. Coinfection with Borrelia turicatae serotype 2 prevents the severe vestibular dysfunction and earlier mortality caused by serotype 1. J. Infect. Dis. 195: 1686-1693.
8. Cadavid, D., A. R. Pachner, L. Estanislao, R. Patalapati, and A. G. Barbour. 2001. Isogenic serotypes of Borrelia turicatae show different localization in the brain and skin of mice. Infect. Immun. 69: 3389-3397.
9. Cadavid, D., D. D. Thomas, R. Crawley, and A. G. Barbour. 1994. Variability of a bacterial surface protein and disease expression in a possible mouse model of systemic Lyme borreliosis. J. Exp. Med. 179: 631-642.
10. Gelderblom, H., D. Londono, Y. Bai, E. S. Cabral, J. Quandt, R. Hornung, R. Martin, A. Marques, and D. Cadavid. 2007. High production of CXCL13 in blood and brain during persistent infection with the relapsing fever spirochete Borrelia turicatae. J. Neuropathol. Exp. Neurol. 66: 208-217.
11. Londoño, D., Y. Bai, W. R. Zuckert, H. Gelderblom, and D. Cadavid. 2005. Cardiac apoptosis in severe relapsing fever borreliosis. Infect. Immun. 73: 7669-7676.
12. Lazarus, J. J., M. J. Meadows, R. E. Lintner, and R. M. Wooten. 2006. IL-10 deficiency promotes increased Borrelia burgdorferi clearance predominantly through enhanced innate immune responses. J. Immunol. 177: 7076-7085.
13. Greenberger, M. J., R. M. Strieter, S. L. Kunkel, J. M. Danforth, R. E. Goodman, and T. J. Standiford. 1995. Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia. J. Immunol. 155: 722-729.
14. Abrahamsohn, I. A., and R. L. Coffman. 1996. Trypanosoma cruzi: IL-10, TNF, IFN-γ, and IL-12 regulate innate and acquired immunity to infection. Exp. Parasitol. 84: 231-244.
15. Kelly, J. P., and G. J. Bancroft. 1996. Administration of interleukin-10 abolishes innate resistance to Listeria monocytogenes. Eur. J. Immunol. 26: 356-364.
16. Pennington, P. M., D. Cadavid, and A. G. Barbour. 1999. Characterization of VspB of Borrelia turicatae, a major outer membrane protein expressed in blood and tissues of mice. Infect. Immun. 67: 4637-4645.
17. Cadavid, D., P. M. Pennington, T. A. Kerentseva, S. Bergstrom, and A. G. Barbour. 1997. Immunologic and genetic analyses of VmpA of a neurotropic strain of Borrelia turicatae. Infect. Immun. 65: 3352-3360.
18. Hesse, M., C. A. Piccirillo, Y. Belkaid, J. Prufer, M. Mentink-Kane, M. Leusink, A. W. Cheever, E. M. Shevach, and T. A. Wynn. 2004. The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells. J. Immunol. 172: 3157-3166.
19. Kullberg, M. C., A. G. Rothfuchs, D. Jankovic, P. Caspar, T. A. Wynn, P. L. Gorelick, A. W. Cheever, and A. Sher. 2001. Helicobacter hepaticus-induced colitis in interleukin-10-deficient mice: cytokine requirements for the induction and maintenance of intestinal inflammation. Infect. Immun. 69: 4232-4241.
20. Li, C., L. A. Sanni, F. Omer, E. Riley, and J. Langhorne. 2003. Pathology of Plasmodium chabaudi chabaudi infection and mortality in interleukin-10-deficient mice are ameliorated by anti-tumor necrosis factor α and exacerbated by anti-transforming growth factor β antibodies. Infect. Immun. 71: 4850-4856.
21. Connolly, S. E., and J. L. Benach. 2001. Cutting edge: the spirochetemia of murine relapsing fever is cleared by complement-independent bactericidal antibodies. J. Immunol. 167: 3029-3032.
22. Brown, J. P., J. F. Zachary, C. Teuscher, J. J. Weis, and R. M. Wooten. 1999. Dual role of interleukin-10 in murine Lyme disease: regulation of arthritis severity and host defense. Infect. Immun. 67: 5142-5150.
23. Marchant, A., M. L. Alegre, A. Hakim, G. Pierard, G. Marecaux, G. Friedman, D. De Groote, R. J. Kahn, J. L. Vincent, and M. Goldman. 1995. Clinical and biological significance of interleukin-10 plasma levels in patients with septic shock. J. Clin. Immunol. 15: 266-273.
24. Marchant, A., J. Deviere, B. Byl, D. De Groote, J. L. Vincent, and M. Goldman. 1994. Interleukin-10 production during septicaemia. Lancet 343: 707-708.
25. Lehmann, A. K., A. Halstensen, S. Sornes, O. Rokke, and A. Waage. 1995. High levels of interleukin 10 in serum are associated with fatality in meningococcal disease. Infect. Immun. 63: 2109-2112.
26. Gomez-Jimenez, J., M. C. Martin, R. Sauri, R. M. Segura, F. Esteban, J. C. Ruiz, X. Nuvials, J. L. Boveda, R. Peracaula, and A. Salgado. 1995. Interleukin-10 and the monocyte/macrophage-induced inflammatory response in septic shock. J. Infect. Dis. 171: 472-475.
27. Bjerre, A., B. Brusletto, E. A. Hoiby, P. Kierulf, and P. Brandtzaeg. 2004. Plasma interferon-γ and interleukin-10 concentrations in systemic meningococcal disease compared with severe systemic Gram-positive septic shock. Crit. Care Med. 32: 433-438.
28. Abe, R., H. Hirasawa, S. Oda, T. Sadahiro, M. Nakamura, E. Watanabe, T. A. Nakada, M. Hatano, and T. Tokuhisa. 2007. Up-regulation of interleukin-10 mRNA expression in peripheral leukocytes predicts poor outcome and diminished human leukocyte antigen-DR expression on monocytes in septic patients. J. Surg. Res. 147: 1-8.
29. Gerard, C., C. Bruyns, A. Marchant, D. Abramowicz, P. Vandenabeele, A. Delvaux, W. Fiers, M. Goldman, and T. Velu. 1993. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J. Exp. Med. 177: 547-550.
30. Berg, D. J., R. Kuhn, K. Rajewsky, W. Muller, S. Menon, N. Davidson, G. Grunig, and D. Rennick. 1995. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J. Clin. Invest. 96: 2339-2347.
31. Howard, M., T. Muchamuel, S. Andrade, and S. Menon. 1993. Interleukin 10 protects mice from lethal endotoxemia. J. Exp. Med. 177: 1205-1208.
32. Hunter, C. A., L. A. Ellis-Neyes, T. Slifer, S. Kanaly, G. Grunig, M. Fort, D. Rennick, and F. G. Araujo. 1997. IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. J. Immunol. 158: 3311-3316.
33. Keel, M., U. Ungethum, U. Steckholzer, E. Niederer, T. Hartung, O. Trentz, and W. Ertel. 1997. Interleukin-10 counterregulates proinflammatory cytokine-induced inhibition of neutrophil apoptosis during severe sepsis. Blood 90: 3356-3363.
34. Deckert, M., S. Soltek, G. Geginat, S. Lutjen, M. Montesinos-Rongen, H. Hof, and D. Schluter. 2001. Endogenous interleukin-10 is required for prevention of a hyperinflammatory intracerebral immune response in Listeria monocytogenes meningoencephalitis. Infect. Immun. 69: 4561-4571.
35. Latifi, S. Q., M. A. O'Riordan, and A. D. Levine. 2002. Interleukin-10 controls the onset of irreversible septic shock. Infect. Immun. 70: 4441-4446.
36. Lisinski, T. J., and M. B. Furie. 2002. Interleukin-10 inhibits proinflammatory activation of endothelium in response to Borrelia burgdorferi or lipopolysaccharide but not interleukin-1β or tumor necrosis factor α. J. Leukocyte Biol. 72: 503-511.
37. Sewnath, M. E., D. P. Olszyna, R. Birjmohun, F. J. ten Kate, D. J. Gouma, and T. van Der Poll. 2001. IL-10-deficient mice demonstrate multiple organ failure and increased mortality during Escherichia coli peritonitis despite an accelerated bacterial clearance. J. Immunol. 166: 6323-6331.
38. Ward, C., J. Murray, A. Clugston, I. Dransfield, C. Haslett, and A. G. Rossi. 2005. Interleukin-10 inhibits lipopolysaccharide-induced survival and extracellular signal-regulated kinase activation in human neutrophils. Eur. J. Immunol. 35: 2728-2737.
39. Tassiulas, I., K. H. Park-Min, Y. Hu, L. Kellerman, D. Mevorach, and L. B. Ivashkiv. 2007. Apoptotic cells inhibit LPS-induced cytokine and chemokine production and IFN responses in macrophages. Hum. Immunol. 68: 156-164.
40. Groesdonk, H. V., F. Wagner, B. Hoffarth, M. Georgieff, and U. Senftleben. 2007. Enhancement of NF-κB activation in lymphocytes prevents T cell apoptosis and improves survival in murine sepsis. J. Immunol. 179: 8083-8089.
41. Wagner, T. H., A. M. Drewry, S. Macmillan, W. M. Dunne, K. C. Chang, I. E. Karl, R. S. Hotchkiss, and J. P. Cobb. 2007. Surviving sepsis: bcl-2 overexpression modulates splenocyte transcriptional responses in vivo. Am. J. Physiol. 292: R1751-1759.
42. Wesche-Soldato, D. E., R. Z. Swan, C. S. Chung, and A. Ayala. 2007. The apoptotic pathway as a therapeutic target in sepsis. Curr. Drug. Targets 8: 493-500.
43. + T cells promote inflammation and apoptosis in the liver after sepsis: role of Fas-FasL. Am. J. Pathol. 171: 87-96.
44. Tinsley, K. W., M. H. Grayson, P. E. Swanson, A. M. Drewry, K. C. Chang, I. E. Karl, and R. S. Hotchkiss. 2003. Sepsis induces apoptosis and profound depletion of splenic interdigitating and follicular dendritic cells. J. Immunol. 171: 909-914.
45. Moore, M. W., A. R. Cruz, C. J. LaVake, A. L. Marzo, C. H. Eggers, J. C. Salazar, and J. D. Radolf. 2007. Phagocytosis of Borrelia burgdorferi and Treponema pallidum potentiates innate immune activation and induces γ interferon production. Infect. Immun. 75: 2046-2062.
46. Strebel, A., F. Bachmann, M. Wernli, and P. Erb. 2002. Tumor necrosis factor-related, apoptosis-inducing ligand supports growth of mouse mastocytoma tumors by killing tumor-infiltrating macrophages. Int. J. Cancer 100: 627-634.
47. Jewett, A., M. Cavalcanti, and B. Bonavida. 1997. Pivotal role of endogenous TNF-α in the induction of functional inactivation and apoptosis in NK cells. J. Immunol. 159: 4815-4822.
48. Alugupalli, K. R., A. D. Michelson, I. Joris, T. G. Schwan, K. Hodivala-Dilke, R. O. Hynes, and J. M. Leong. 2003. Spirochete-platelet attachment and thrombocytopenia in murine relapsing fever borreliosis. Blood 102: 2843-2850.
49. Aguero-Rosenfeld, M. E., G. Wang, I. Schwartz, and G. P. Wormser. 2005. Diagnosis of Lyme borreliosis. Clin. Microbiol. Rev. 18: 484-509.
50. Cadavid, D. 2006. The mammalian host response to Borrelia infection. Wien. Klin. Wochenschr. 118: 653-658.
51. Cooper, P. J., D. Fekade, D. G. Remick, P. Grint, J. Wherry, and G. E. Griffin. 2000. Recombinant human interleukin-10 fails to alter proinflammatory cytokine production or physiologic changes associated with the Jarisch-Herxheimer reaction. J. Infect. Dis. 181: 203-209.